Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
6,666
archived clinical trials in
Hospital

Casopitant And ZOFRAN To Prevent Post Operative Nausea And Vomiting In Women
A Phase III Multicenter, Randomized, Double-blind, Parallel Group Study to Evaluate the Safety and Efficacy of the 30 mg Intravenous Formulation of the Neurokinin-1 Receptor Antagonist GW679769 for Prevention of Postoperative Nausea and Vomiting in Female Subjects at High Risk for Emesis
Status: Enrolling
Updated:  3/21/2017
GSK Investigational Site
1290
mi
from
New York, NY
Casopitant And ZOFRAN To Prevent Post Operative Nausea And Vomiting In Women
A Phase III Multicenter, Randomized, Double-blind, Parallel Group Study to Evaluate the Safety and Efficacy of the 30 mg Intravenous Formulation of the Neurokinin-1 Receptor Antagonist GW679769 for Prevention of Postoperative Nausea and Vomiting in Female Subjects at High Risk for Emesis
Status: Enrolling
Updated: 3/21/2017
GSK Investigational Site
1290
mi
from
New York, NY
Click here to add this to my saved trials
Casopitant And ZOFRAN To Prevent Post Operative Nausea And Vomiting In Women
A Phase III Multicenter, Randomized, Double-blind, Parallel Group Study to Evaluate the Safety and Efficacy of the 30 mg Intravenous Formulation of the Neurokinin-1 Receptor Antagonist GW679769 for Prevention of Postoperative Nausea and Vomiting in Female Subjects at High Risk for Emesis
Status: Enrolling
Updated:  3/21/2017
GSK Investigational Site
971
mi
from
Winston-Salem, NC
Casopitant And ZOFRAN To Prevent Post Operative Nausea And Vomiting In Women
A Phase III Multicenter, Randomized, Double-blind, Parallel Group Study to Evaluate the Safety and Efficacy of the 30 mg Intravenous Formulation of the Neurokinin-1 Receptor Antagonist GW679769 for Prevention of Postoperative Nausea and Vomiting in Female Subjects at High Risk for Emesis
Status: Enrolling
Updated: 3/21/2017
GSK Investigational Site
971
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
Casopitant And ZOFRAN To Prevent Post Operative Nausea And Vomiting In Women
A Phase III Multicenter, Randomized, Double-blind, Parallel Group Study to Evaluate the Safety and Efficacy of the 30 mg Intravenous Formulation of the Neurokinin-1 Receptor Antagonist GW679769 for Prevention of Postoperative Nausea and Vomiting in Female Subjects at High Risk for Emesis
Status: Enrolling
Updated:  3/21/2017
GSK Investigational Site
727
mi
from
Cincinnati, OH
Casopitant And ZOFRAN To Prevent Post Operative Nausea And Vomiting In Women
A Phase III Multicenter, Randomized, Double-blind, Parallel Group Study to Evaluate the Safety and Efficacy of the 30 mg Intravenous Formulation of the Neurokinin-1 Receptor Antagonist GW679769 for Prevention of Postoperative Nausea and Vomiting in Female Subjects at High Risk for Emesis
Status: Enrolling
Updated: 3/21/2017
GSK Investigational Site
727
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Casopitant And ZOFRAN To Prevent Post Operative Nausea And Vomiting In Women
A Phase III Multicenter, Randomized, Double-blind, Parallel Group Study to Evaluate the Safety and Efficacy of the 30 mg Intravenous Formulation of the Neurokinin-1 Receptor Antagonist GW679769 for Prevention of Postoperative Nausea and Vomiting in Female Subjects at High Risk for Emesis
Status: Enrolling
Updated:  3/21/2017
GSK Investigational Site
155
mi
from
Oklahoma City, OK
Casopitant And ZOFRAN To Prevent Post Operative Nausea And Vomiting In Women
A Phase III Multicenter, Randomized, Double-blind, Parallel Group Study to Evaluate the Safety and Efficacy of the 30 mg Intravenous Formulation of the Neurokinin-1 Receptor Antagonist GW679769 for Prevention of Postoperative Nausea and Vomiting in Female Subjects at High Risk for Emesis
Status: Enrolling
Updated: 3/21/2017
GSK Investigational Site
155
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Casopitant And ZOFRAN To Prevent Post Operative Nausea And Vomiting In Women
A Phase III Multicenter, Randomized, Double-blind, Parallel Group Study to Evaluate the Safety and Efficacy of the 30 mg Intravenous Formulation of the Neurokinin-1 Receptor Antagonist GW679769 for Prevention of Postoperative Nausea and Vomiting in Female Subjects at High Risk for Emesis
Status: Enrolling
Updated:  3/21/2017
GSK Investigational Site
1053
mi
from
Charlottesville, VA
Casopitant And ZOFRAN To Prevent Post Operative Nausea And Vomiting In Women
A Phase III Multicenter, Randomized, Double-blind, Parallel Group Study to Evaluate the Safety and Efficacy of the 30 mg Intravenous Formulation of the Neurokinin-1 Receptor Antagonist GW679769 for Prevention of Postoperative Nausea and Vomiting in Female Subjects at High Risk for Emesis
Status: Enrolling
Updated: 3/21/2017
GSK Investigational Site
1053
mi
from
Charlottesville, VA
Click here to add this to my saved trials
Casopitant And ZOFRAN To Prevent Post Operative Nausea And Vomiting In Women
A Phase III Multicenter, Randomized, Double-blind, Parallel Group Study to Evaluate the Safety and Efficacy of the 30 mg Intravenous Formulation of the Neurokinin-1 Receptor Antagonist GW679769 for Prevention of Postoperative Nausea and Vomiting in Female Subjects at High Risk for Emesis
Status: Enrolling
Updated:  3/21/2017
GSK Investigational Site
1065
mi
from
Winchester, VA
Casopitant And ZOFRAN To Prevent Post Operative Nausea And Vomiting In Women
A Phase III Multicenter, Randomized, Double-blind, Parallel Group Study to Evaluate the Safety and Efficacy of the 30 mg Intravenous Formulation of the Neurokinin-1 Receptor Antagonist GW679769 for Prevention of Postoperative Nausea and Vomiting in Female Subjects at High Risk for Emesis
Status: Enrolling
Updated: 3/21/2017
GSK Investigational Site
1065
mi
from
Winchester, VA
Click here to add this to my saved trials
Casopitant And ZOFRAN To Prevent Post Operative Nausea And Vomiting In Women
A Phase III Multicenter, Randomized, Double-blind, Parallel Group Study to Evaluate the Safety and Efficacy of the 30 mg Intravenous Formulation of the Neurokinin-1 Receptor Antagonist GW679769 for Prevention of Postoperative Nausea and Vomiting in Female Subjects at High Risk for Emesis
Status: Enrolling
Updated:  3/21/2017
GSK Investigational Site
1411
mi
from
Seattle, WA
Casopitant And ZOFRAN To Prevent Post Operative Nausea And Vomiting In Women
A Phase III Multicenter, Randomized, Double-blind, Parallel Group Study to Evaluate the Safety and Efficacy of the 30 mg Intravenous Formulation of the Neurokinin-1 Receptor Antagonist GW679769 for Prevention of Postoperative Nausea and Vomiting in Female Subjects at High Risk for Emesis
Status: Enrolling
Updated: 3/21/2017
GSK Investigational Site
1411
mi
from
Seattle, WA
Click here to add this to my saved trials
Casopitant And ZOFRAN To Prevent Post Operative Nausea And Vomiting In Women
A Phase III Multicenter, Randomized, Double-blind, Parallel Group Study to Evaluate the Safety and Efficacy of the 30 mg Intravenous Formulation of the Neurokinin-1 Receptor Antagonist GW679769 for Prevention of Postoperative Nausea and Vomiting in Female Subjects at High Risk for Emesis
Status: Enrolling
Updated:  3/21/2017
GSK Investigational Site
mi
from
Aalst,
Casopitant And ZOFRAN To Prevent Post Operative Nausea And Vomiting In Women
A Phase III Multicenter, Randomized, Double-blind, Parallel Group Study to Evaluate the Safety and Efficacy of the 30 mg Intravenous Formulation of the Neurokinin-1 Receptor Antagonist GW679769 for Prevention of Postoperative Nausea and Vomiting in Female Subjects at High Risk for Emesis
Status: Enrolling
Updated: 3/21/2017
GSK Investigational Site
mi
from
Aalst,
Click here to add this to my saved trials
Broad-spectrum Cognitive Remediation: Effects of a Brain Plasticity-based Program in Mild Traumatic Brain Injury
BRAVE Trial: Broad-spectrum Cognitive Remediation Available to Veterans: Effects of a Brain Plasticity-based Program in Mild Traumatic Brain Injury (mTBI)
Status: Enrolling
Updated:  3/27/2017
Posit Science Corporation
1338
mi
from
San Francisco, CA
Broad-spectrum Cognitive Remediation: Effects of a Brain Plasticity-based Program in Mild Traumatic Brain Injury
BRAVE Trial: Broad-spectrum Cognitive Remediation Available to Veterans: Effects of a Brain Plasticity-based Program in Mild Traumatic Brain Injury (mTBI)
Status: Enrolling
Updated: 3/27/2017
Posit Science Corporation
1338
mi
from
San Francisco, CA
Click here to add this to my saved trials
Next Science Wound Gel Efficacy in Chronic Wound Versus Standard of Care
Clinical Assessment of the Next Science Wound Gel Efficacy in Chronic Wound Compared to Standard of Care
Status: Enrolling
Updated:  3/27/2017
Mayo Clinic Florida
1066
mi
from
Jacksonville, FL
Next Science Wound Gel Efficacy in Chronic Wound Versus Standard of Care
Clinical Assessment of the Next Science Wound Gel Efficacy in Chronic Wound Compared to Standard of Care
Status: Enrolling
Updated: 3/27/2017
Mayo Clinic Florida
1066
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Next Science Wound Gel Efficacy in Chronic Wound Versus Standard of Care
Clinical Assessment of the Next Science Wound Gel Efficacy in Chronic Wound Compared to Standard of Care
Status: Enrolling
Updated:  3/27/2017
Jacksonville Center for Clinical Research - RCCR location
1065
mi
from
Jacksonville, FL
Next Science Wound Gel Efficacy in Chronic Wound Versus Standard of Care
Clinical Assessment of the Next Science Wound Gel Efficacy in Chronic Wound Compared to Standard of Care
Status: Enrolling
Updated: 3/27/2017
Jacksonville Center for Clinical Research - RCCR location
1065
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Characterization of the Early Sex Hormone Milieu Post Injury and Relationship With Resuscitation Requirements and Coagulopathy
Characterization of the Early Sex Hormone Milieu Post Injury and Relationship With Resuscitation Requirements and Coagulopathy
Status: Enrolling
Updated:  3/28/2017
UPMC
974
mi
from
Pittsburgh, PA
Characterization of the Early Sex Hormone Milieu Post Injury and Relationship With Resuscitation Requirements and Coagulopathy
Characterization of the Early Sex Hormone Milieu Post Injury and Relationship With Resuscitation Requirements and Coagulopathy
Status: Enrolling
Updated: 3/28/2017
UPMC
974
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Evaluation of Objective Outcomes With the Use of an Activity Tracker During the Trial Period of Spinal Cord Stimulation
Status: Enrolling
Updated:  3/29/2017
Lawrence J. Ellison Ambulatory Care Center
1281
mi
from
Sacramento, CA
Evaluation of Objective Outcomes With the Use of an Activity Tracker During the Trial Period of Spinal Cord Stimulation
Status: Enrolling
Updated: 3/29/2017
Lawrence J. Ellison Ambulatory Care Center
1281
mi
from
Sacramento, CA
Click here to add this to my saved trials
Helping Children With Trauma
Helping Children With Trauma
Status: Enrolling
Updated:  3/30/2017
NYU Langone Medical Center
1288
mi
from
New York, NY
Helping Children With Trauma
Helping Children With Trauma
Status: Enrolling
Updated: 3/30/2017
NYU Langone Medical Center
1288
mi
from
New York, NY
Click here to add this to my saved trials
Sublingual Fentanyl and Procedural Burn Pain
A Randomized, Double-blind, Placebo-controlled, Cross-over Trial of Sublingual Fentanyl Spray (Subsys) and Oral Morphine for Procedural Wound Care in Adult Patients With Burn Injury Pain
Status: Enrolling
Updated:  4/3/2017
Loyola University Medical Center Burn Unit
600
mi
from
Maywood, IL
Sublingual Fentanyl and Procedural Burn Pain
A Randomized, Double-blind, Placebo-controlled, Cross-over Trial of Sublingual Fentanyl Spray (Subsys) and Oral Morphine for Procedural Wound Care in Adult Patients With Burn Injury Pain
Status: Enrolling
Updated: 4/3/2017
Loyola University Medical Center Burn Unit
600
mi
from
Maywood, IL
Click here to add this to my saved trials
Trial of Supplemental Parenteral Nutrition in Under and Over Weight Critically Ill Patients (TOP-UP)
A Randomized Trial of Supplemental Parenteral Nutrition in Under and Over Weight Critically Ill Patients: The TOP UP Trial (Pilot)
Status: Enrolling
Updated:  4/4/2017
University of Colorado DHSC
430
mi
from
Boulder, CO
Trial of Supplemental Parenteral Nutrition in Under and Over Weight Critically Ill Patients (TOP-UP)
A Randomized Trial of Supplemental Parenteral Nutrition in Under and Over Weight Critically Ill Patients: The TOP UP Trial (Pilot)
Status: Enrolling
Updated: 4/4/2017
University of Colorado DHSC
430
mi
from
Boulder, CO
Click here to add this to my saved trials
Trial of Supplemental Parenteral Nutrition in Under and Over Weight Critically Ill Patients (TOP-UP)
A Randomized Trial of Supplemental Parenteral Nutrition in Under and Over Weight Critically Ill Patients: The TOP UP Trial (Pilot)
Status: Enrolling
Updated:  4/4/2017
Mercy Hospital St. Louis
418
mi
from
St. Louis, MO
Trial of Supplemental Parenteral Nutrition in Under and Over Weight Critically Ill Patients (TOP-UP)
A Randomized Trial of Supplemental Parenteral Nutrition in Under and Over Weight Critically Ill Patients: The TOP UP Trial (Pilot)
Status: Enrolling
Updated: 4/4/2017
Mercy Hospital St. Louis
418
mi
from
St. Louis, MO
Click here to add this to my saved trials
Trial of Supplemental Parenteral Nutrition in Under and Over Weight Critically Ill Patients (TOP-UP)
A Randomized Trial of Supplemental Parenteral Nutrition in Under and Over Weight Critically Ill Patients: The TOP UP Trial (Pilot)
Status: Enrolling
Updated:  4/4/2017
Washington University School of Medicine in St. Louis
414
mi
from
St. Louis, MO
Trial of Supplemental Parenteral Nutrition in Under and Over Weight Critically Ill Patients (TOP-UP)
A Randomized Trial of Supplemental Parenteral Nutrition in Under and Over Weight Critically Ill Patients: The TOP UP Trial (Pilot)
Status: Enrolling
Updated: 4/4/2017
Washington University School of Medicine in St. Louis
414
mi
from
St. Louis, MO
Click here to add this to my saved trials
Trial of Supplemental Parenteral Nutrition in Under and Over Weight Critically Ill Patients (TOP-UP)
A Randomized Trial of Supplemental Parenteral Nutrition in Under and Over Weight Critically Ill Patients: The TOP UP Trial (Pilot)
Status: Enrolling
Updated:  4/4/2017
Cleveland Clinic Lerner College of Medicine
898
mi
from
Cleveland, OH
Trial of Supplemental Parenteral Nutrition in Under and Over Weight Critically Ill Patients (TOP-UP)
A Randomized Trial of Supplemental Parenteral Nutrition in Under and Over Weight Critically Ill Patients: The TOP UP Trial (Pilot)
Status: Enrolling
Updated: 4/4/2017
Cleveland Clinic Lerner College of Medicine
898
mi
from
Cleveland, OH
Click here to add this to my saved trials
Trial of Supplemental Parenteral Nutrition in Under and Over Weight Critically Ill Patients (TOP-UP)
A Randomized Trial of Supplemental Parenteral Nutrition in Under and Over Weight Critically Ill Patients: The TOP UP Trial (Pilot)
Status: Enrolling
Updated:  4/4/2017
The Ohio State Univsersity Medical Center
810
mi
from
Columbus, OH
Trial of Supplemental Parenteral Nutrition in Under and Over Weight Critically Ill Patients (TOP-UP)
A Randomized Trial of Supplemental Parenteral Nutrition in Under and Over Weight Critically Ill Patients: The TOP UP Trial (Pilot)
Status: Enrolling
Updated: 4/4/2017
The Ohio State Univsersity Medical Center
810
mi
from
Columbus, OH
Click here to add this to my saved trials
Trial of Supplemental Parenteral Nutrition in Under and Over Weight Critically Ill Patients (TOP-UP)
A Randomized Trial of Supplemental Parenteral Nutrition in Under and Over Weight Critically Ill Patients: The TOP UP Trial (Pilot)
Status: Enrolling
Updated:  4/4/2017
Oregon Health and Science University
1383
mi
from
Portland, OR
Trial of Supplemental Parenteral Nutrition in Under and Over Weight Critically Ill Patients (TOP-UP)
A Randomized Trial of Supplemental Parenteral Nutrition in Under and Over Weight Critically Ill Patients: The TOP UP Trial (Pilot)
Status: Enrolling
Updated: 4/4/2017
Oregon Health and Science University
1383
mi
from
Portland, OR
Click here to add this to my saved trials
Trial of Supplemental Parenteral Nutrition in Under and Over Weight Critically Ill Patients (TOP-UP)
A Randomized Trial of Supplemental Parenteral Nutrition in Under and Over Weight Critically Ill Patients: The TOP UP Trial (Pilot)
Status: Enrolling
Updated:  4/4/2017
University of Texas Health Science Center
572
mi
from
Houston, TX
Trial of Supplemental Parenteral Nutrition in Under and Over Weight Critically Ill Patients (TOP-UP)
A Randomized Trial of Supplemental Parenteral Nutrition in Under and Over Weight Critically Ill Patients: The TOP UP Trial (Pilot)
Status: Enrolling
Updated: 4/4/2017
University of Texas Health Science Center
572
mi
from
Houston, TX
Click here to add this to my saved trials
Trial of Supplemental Parenteral Nutrition in Under and Over Weight Critically Ill Patients (TOP-UP)
A Randomized Trial of Supplemental Parenteral Nutrition in Under and Over Weight Critically Ill Patients: The TOP UP Trial (Pilot)
Status: Enrolling
Updated:  4/4/2017
Erasme University Hospital
4718
mi
from
Brussels,
Trial of Supplemental Parenteral Nutrition in Under and Over Weight Critically Ill Patients (TOP-UP)
A Randomized Trial of Supplemental Parenteral Nutrition in Under and Over Weight Critically Ill Patients: The TOP UP Trial (Pilot)
Status: Enrolling
Updated: 4/4/2017
Erasme University Hospital
4718
mi
from
Brussels,
Click here to add this to my saved trials
Prospective Evaluation of Computerized Physician Order Entry in the Emergency Department
Prospective Evaluation of Computerized Physician Order Entry in the Emergency Department
Status: Enrolling
Updated:  4/4/2017
Beth Israel Deaconess Medical Center
1444
mi
from
Boston, MA
Prospective Evaluation of Computerized Physician Order Entry in the Emergency Department
Prospective Evaluation of Computerized Physician Order Entry in the Emergency Department
Status: Enrolling
Updated: 4/4/2017
Beth Israel Deaconess Medical Center
1444
mi
from
Boston, MA
Click here to add this to my saved trials
Comparing an Automated to a Conventional Sepsis Clinical Prediction Rule
Comparing an Automated to a Conventional Sepsis Clinical Prediction Rule
Status: Enrolling
Updated:  4/4/2017
Beth Israel Deaconess Medical Center
1444
mi
from
Boston, MA
Comparing an Automated to a Conventional Sepsis Clinical Prediction Rule
Comparing an Automated to a Conventional Sepsis Clinical Prediction Rule
Status: Enrolling
Updated: 4/4/2017
Beth Israel Deaconess Medical Center
1444
mi
from
Boston, MA
Click here to add this to my saved trials
Noninvasive Neuromodulation for Treatment of Symptoms Due to Mild or Moderate Traumatic Brain Injury
Cranial Nerve Noninvasive Neuromodulation Using the PoNS for Treatment of Symptoms Due to Mild or Moderate Traumatic Brain Injury
Status: Enrolling
Updated:  4/4/2017
TCNL, Department of Kinesiology, UW Madison
575
mi
from
Madison, WI
Noninvasive Neuromodulation for Treatment of Symptoms Due to Mild or Moderate Traumatic Brain Injury
Cranial Nerve Noninvasive Neuromodulation Using the PoNS for Treatment of Symptoms Due to Mild or Moderate Traumatic Brain Injury
Status: Enrolling
Updated: 4/4/2017
TCNL, Department of Kinesiology, UW Madison
575
mi
from
Madison, WI
Click here to add this to my saved trials
A Safety, Tolerability and Efficacy Study of V158866 in Central Neuropathic Pain Following Spinal Cord Injury
A Phase IIa, Randomized, Double-blind, Placebo-controlled, Two-period Cross-over Study Evaluating the Safety, Tolerability and Efficacy of V158866 in Central Neuropathic Pain Following Spinal Cord Injury
Status: Enrolling
Updated:  4/10/2017
Translational Pain Research, Brigham and Women's Hospital
1442
mi
from
Boston, MA
A Safety, Tolerability and Efficacy Study of V158866 in Central Neuropathic Pain Following Spinal Cord Injury
A Phase IIa, Randomized, Double-blind, Placebo-controlled, Two-period Cross-over Study Evaluating the Safety, Tolerability and Efficacy of V158866 in Central Neuropathic Pain Following Spinal Cord Injury
Status: Enrolling
Updated: 4/10/2017
Translational Pain Research, Brigham and Women's Hospital
1442
mi
from
Boston, MA
Click here to add this to my saved trials
The Role of Dysfunctional HDL in Severe Sepsis
The Role of Dysfunctional HDL in Severe Sepsis
Status: Enrolling
Updated:  4/11/2017
UF Health Jacksonville
1055
mi
from
Jacksonville, FL
The Role of Dysfunctional HDL in Severe Sepsis
The Role of Dysfunctional HDL in Severe Sepsis
Status: Enrolling
Updated: 4/11/2017
UF Health Jacksonville
1055
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Applying Platelet Rich Plasma (PRP) Gel to Acute Deep Partial Thickness Thermal Injuries
Phase I, Double-Blind, Randomized, Controlled Study to Demonstrate the Safety of Applying Autologous Platelet Rich Plasma (PRP) Gel (Magellan® Bio-Bandage™) to Acute Deep Partial Thickness Thermal Injuries
Status: Enrolling
Updated:  4/12/2017
Arizona Burn Center
848
mi
from
Phoenix, AZ
Applying Platelet Rich Plasma (PRP) Gel to Acute Deep Partial Thickness Thermal Injuries
Phase I, Double-Blind, Randomized, Controlled Study to Demonstrate the Safety of Applying Autologous Platelet Rich Plasma (PRP) Gel (Magellan® Bio-Bandage™) to Acute Deep Partial Thickness Thermal Injuries
Status: Enrolling
Updated: 4/12/2017
Arizona Burn Center
848
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Applying Platelet Rich Plasma (PRP) Gel to Acute Deep Partial Thickness Thermal Injuries
Phase I, Double-Blind, Randomized, Controlled Study to Demonstrate the Safety of Applying Autologous Platelet Rich Plasma (PRP) Gel (Magellan® Bio-Bandage™) to Acute Deep Partial Thickness Thermal Injuries
Status: Enrolling
Updated:  4/12/2017
MedStar Health Research Institute
1127
mi
from
Washington,
Applying Platelet Rich Plasma (PRP) Gel to Acute Deep Partial Thickness Thermal Injuries
Phase I, Double-Blind, Randomized, Controlled Study to Demonstrate the Safety of Applying Autologous Platelet Rich Plasma (PRP) Gel (Magellan® Bio-Bandage™) to Acute Deep Partial Thickness Thermal Injuries
Status: Enrolling
Updated: 4/12/2017
MedStar Health Research Institute
1127
mi
from
Washington,
Click here to add this to my saved trials
Applying Platelet Rich Plasma (PRP) Gel to Acute Deep Partial Thickness Thermal Injuries
Phase I, Double-Blind, Randomized, Controlled Study to Demonstrate the Safety of Applying Autologous Platelet Rich Plasma (PRP) Gel (Magellan® Bio-Bandage™) to Acute Deep Partial Thickness Thermal Injuries
Status: Enrolling
Updated:  4/12/2017
Tampa General Hospital/University of South Florida
1117
mi
from
Tampa, FL
Applying Platelet Rich Plasma (PRP) Gel to Acute Deep Partial Thickness Thermal Injuries
Phase I, Double-Blind, Randomized, Controlled Study to Demonstrate the Safety of Applying Autologous Platelet Rich Plasma (PRP) Gel (Magellan® Bio-Bandage™) to Acute Deep Partial Thickness Thermal Injuries
Status: Enrolling
Updated: 4/12/2017
Tampa General Hospital/University of South Florida
1117
mi
from
Tampa, FL
Click here to add this to my saved trials
Applying Platelet Rich Plasma (PRP) Gel to Acute Deep Partial Thickness Thermal Injuries
Phase I, Double-Blind, Randomized, Controlled Study to Demonstrate the Safety of Applying Autologous Platelet Rich Plasma (PRP) Gel (Magellan® Bio-Bandage™) to Acute Deep Partial Thickness Thermal Injuries
Status: Enrolling
Updated:  4/12/2017
Jaycee Burn Center at University of North Carolina
843
mi
from
Chapel Hill, NC
Applying Platelet Rich Plasma (PRP) Gel to Acute Deep Partial Thickness Thermal Injuries
Phase I, Double-Blind, Randomized, Controlled Study to Demonstrate the Safety of Applying Autologous Platelet Rich Plasma (PRP) Gel (Magellan® Bio-Bandage™) to Acute Deep Partial Thickness Thermal Injuries
Status: Enrolling
Updated: 4/12/2017
Jaycee Burn Center at University of North Carolina
843
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Applying Platelet Rich Plasma (PRP) Gel to Acute Deep Partial Thickness Thermal Injuries
Phase I, Double-Blind, Randomized, Controlled Study to Demonstrate the Safety of Applying Autologous Platelet Rich Plasma (PRP) Gel (Magellan® Bio-Bandage™) to Acute Deep Partial Thickness Thermal Injuries
Status: Enrolling
Updated:  4/12/2017
Lehigh Valley Health Network
1210
mi
from
Allentown, PA
Applying Platelet Rich Plasma (PRP) Gel to Acute Deep Partial Thickness Thermal Injuries
Phase I, Double-Blind, Randomized, Controlled Study to Demonstrate the Safety of Applying Autologous Platelet Rich Plasma (PRP) Gel (Magellan® Bio-Bandage™) to Acute Deep Partial Thickness Thermal Injuries
Status: Enrolling
Updated: 4/12/2017
Lehigh Valley Health Network
1210
mi
from
Allentown, PA
Click here to add this to my saved trials
Applying Platelet Rich Plasma (PRP) Gel to Acute Deep Partial Thickness Thermal Injuries
Phase I, Double-Blind, Randomized, Controlled Study to Demonstrate the Safety of Applying Autologous Platelet Rich Plasma (PRP) Gel (Magellan® Bio-Bandage™) to Acute Deep Partial Thickness Thermal Injuries
Status: Enrolling
Updated:  4/12/2017
Firefighter's Regional Burn Center
467
mi
from
Memphis, TN
Applying Platelet Rich Plasma (PRP) Gel to Acute Deep Partial Thickness Thermal Injuries
Phase I, Double-Blind, Randomized, Controlled Study to Demonstrate the Safety of Applying Autologous Platelet Rich Plasma (PRP) Gel (Magellan® Bio-Bandage™) to Acute Deep Partial Thickness Thermal Injuries
Status: Enrolling
Updated: 4/12/2017
Firefighter's Regional Burn Center
467
mi
from
Memphis, TN
Click here to add this to my saved trials
Applying Platelet Rich Plasma (PRP) Gel to Acute Deep Partial Thickness Thermal Injuries
Phase I, Double-Blind, Randomized, Controlled Study to Demonstrate the Safety of Applying Autologous Platelet Rich Plasma (PRP) Gel (Magellan® Bio-Bandage™) to Acute Deep Partial Thickness Thermal Injuries
Status: Enrolling
Updated:  4/12/2017
University of California, Davis Medica Center
1281
mi
from
Sacramento, CA
Applying Platelet Rich Plasma (PRP) Gel to Acute Deep Partial Thickness Thermal Injuries
Phase I, Double-Blind, Randomized, Controlled Study to Demonstrate the Safety of Applying Autologous Platelet Rich Plasma (PRP) Gel (Magellan® Bio-Bandage™) to Acute Deep Partial Thickness Thermal Injuries
Status: Enrolling
Updated: 4/12/2017
University of California, Davis Medica Center
1281
mi
from
Sacramento, CA
Click here to add this to my saved trials
Applying Platelet Rich Plasma (PRP) Gel to Acute Deep Partial Thickness Thermal Injuries
Phase I, Double-Blind, Randomized, Controlled Study to Demonstrate the Safety of Applying Autologous Platelet Rich Plasma (PRP) Gel (Magellan® Bio-Bandage™) to Acute Deep Partial Thickness Thermal Injuries
Status: Enrolling
Updated:  4/12/2017
University Medical Center Southern Nevada, Lions Regional Burn Center
963
mi
from
Las Vegas, NV
Applying Platelet Rich Plasma (PRP) Gel to Acute Deep Partial Thickness Thermal Injuries
Phase I, Double-Blind, Randomized, Controlled Study to Demonstrate the Safety of Applying Autologous Platelet Rich Plasma (PRP) Gel (Magellan® Bio-Bandage™) to Acute Deep Partial Thickness Thermal Injuries
Status: Enrolling
Updated: 4/12/2017
University Medical Center Southern Nevada, Lions Regional Burn Center
963
mi
from
Las Vegas, NV
Click here to add this to my saved trials
IMproved PREdiction of Severe Sepsis in the Emergency Department
Prospective, Non-interventional, Multi-centre Clinical Study to Assess the Clinical Validity of the Heparin Binding Protein (HBP) Assay for Indicating the Presence, or Outcome, of Severe Sepsis (Including Septic Shock), Over 72 Hours, in Patients With Suspected Infection Following Emergency Department Admission.
Status: Enrolling
Updated:  4/13/2017
Cooper University Hospital
1227
mi
from
Camden, NJ
IMproved PREdiction of Severe Sepsis in the Emergency Department
Prospective, Non-interventional, Multi-centre Clinical Study to Assess the Clinical Validity of the Heparin Binding Protein (HBP) Assay for Indicating the Presence, or Outcome, of Severe Sepsis (Including Septic Shock), Over 72 Hours, in Patients With Suspected Infection Following Emergency Department Admission.
Status: Enrolling
Updated: 4/13/2017
Cooper University Hospital
1227
mi
from
Camden, NJ
Click here to add this to my saved trials
IMproved PREdiction of Severe Sepsis in the Emergency Department
Prospective, Non-interventional, Multi-centre Clinical Study to Assess the Clinical Validity of the Heparin Binding Protein (HBP) Assay for Indicating the Presence, or Outcome, of Severe Sepsis (Including Septic Shock), Over 72 Hours, in Patients With Suspected Infection Following Emergency Department Admission.
Status: Enrolling
Updated:  4/13/2017
Universitetssjukhuset i Linkoping
4774
mi
from
Linkoping,
IMproved PREdiction of Severe Sepsis in the Emergency Department
Prospective, Non-interventional, Multi-centre Clinical Study to Assess the Clinical Validity of the Heparin Binding Protein (HBP) Assay for Indicating the Presence, or Outcome, of Severe Sepsis (Including Septic Shock), Over 72 Hours, in Patients With Suspected Infection Following Emergency Department Admission.
Status: Enrolling
Updated: 4/13/2017
Universitetssjukhuset i Linkoping
4774
mi
from
Linkoping,
Click here to add this to my saved trials
Persistent Pain Among Elderly Experiencing Motor Vehicle Collision
Persistent Pain and Associated Functional Decline Among Elderly Experiencing Motor Vehicle Collision
Status: Enrolling
Updated:  4/18/2017
Spectrum Health Butterworth Hospital
944
mi
from
Grand Rapids, MI
Persistent Pain Among Elderly Experiencing Motor Vehicle Collision
Persistent Pain and Associated Functional Decline Among Elderly Experiencing Motor Vehicle Collision
Status: Enrolling
Updated: 4/18/2017
Spectrum Health Butterworth Hospital
944
mi
from
Grand Rapids, MI
Click here to add this to my saved trials
Testing Devices That Involve the Sense of Touch in Subjects With Traumatic Brain Injury
Testing Subjects With Traumatic Brain Injury Using Haptic Technology
Status: Enrolling
Updated:  4/19/2017
National Institutes of Health Clinical Center, 9000 Rockville Pike
1123
mi
from
Bethesda, MD
Testing Devices That Involve the Sense of Touch in Subjects With Traumatic Brain Injury
Testing Subjects With Traumatic Brain Injury Using Haptic Technology
Status: Enrolling
Updated: 4/19/2017
National Institutes of Health Clinical Center, 9000 Rockville Pike
1123
mi
from
Bethesda, MD
Click here to add this to my saved trials
A Randomized Controlled Trial of a Conservative Fluid Balance Strategy for Patients With Sepsis and Cardiopulmonary Dysfunction (BALANCE Study)
A Phase II/III Randomized Controlled Trial of a Conservative Fluid Balance Strategy for Patients With Sepsis and Cardiopulmonary Dysfunction
Status: Enrolling
Updated:  4/19/2017
Vanderbilt University Medical Center
618
mi
from
Nashville, TN
A Randomized Controlled Trial of a Conservative Fluid Balance Strategy for Patients With Sepsis and Cardiopulmonary Dysfunction (BALANCE Study)
A Phase II/III Randomized Controlled Trial of a Conservative Fluid Balance Strategy for Patients With Sepsis and Cardiopulmonary Dysfunction
Status: Enrolling
Updated: 4/19/2017
Vanderbilt University Medical Center
618
mi
from
Nashville, TN
Click here to add this to my saved trials
Safety and Efficacy Study of FS 4 IU VH S/D (Fibrin Sealant With 4IU/mL Thrombin, Vapor Heated, Solvent/Detergent Treated) to Adhere Split Thickness Skin Grafts and Improve Wound Healing in Burn Patients
A Study To Evaluate the Safety and Efficacy of Fibrin Sealant With 4IU/mL Thrombin, Vapor Heated, Solvent Detergent Treated (FS 4IU VH S/D) to Adhere Tissues and Improve Wound Healing
Status: Enrolling
Updated:  4/19/2017
Clinical Research Facility
683
mi
from
Birmingham, AL
Safety and Efficacy Study of FS 4 IU VH S/D (Fibrin Sealant With 4IU/mL Thrombin, Vapor Heated, Solvent/Detergent Treated) to Adhere Split Thickness Skin Grafts and Improve Wound Healing in Burn Patients
A Study To Evaluate the Safety and Efficacy of Fibrin Sealant With 4IU/mL Thrombin, Vapor Heated, Solvent Detergent Treated (FS 4IU VH S/D) to Adhere Tissues and Improve Wound Healing
Status: Enrolling
Updated: 4/19/2017
Clinical Research Facility
683
mi
from
Birmingham, AL
Click here to add this to my saved trials
Safety and Efficacy Study of FS 4 IU VH S/D (Fibrin Sealant With 4IU/mL Thrombin, Vapor Heated, Solvent/Detergent Treated) to Adhere Split Thickness Skin Grafts and Improve Wound Healing in Burn Patients
A Study To Evaluate the Safety and Efficacy of Fibrin Sealant With 4IU/mL Thrombin, Vapor Heated, Solvent Detergent Treated (FS 4IU VH S/D) to Adhere Tissues and Improve Wound Healing
Status: Enrolling
Updated:  4/19/2017
Clinical Research Facility
740
mi
from
Mobile, AL
Safety and Efficacy Study of FS 4 IU VH S/D (Fibrin Sealant With 4IU/mL Thrombin, Vapor Heated, Solvent/Detergent Treated) to Adhere Split Thickness Skin Grafts and Improve Wound Healing in Burn Patients
A Study To Evaluate the Safety and Efficacy of Fibrin Sealant With 4IU/mL Thrombin, Vapor Heated, Solvent Detergent Treated (FS 4IU VH S/D) to Adhere Tissues and Improve Wound Healing
Status: Enrolling
Updated: 4/19/2017
Clinical Research Facility
740
mi
from
Mobile, AL
Click here to add this to my saved trials
Safety and Efficacy Study of FS 4 IU VH S/D (Fibrin Sealant With 4IU/mL Thrombin, Vapor Heated, Solvent/Detergent Treated) to Adhere Split Thickness Skin Grafts and Improve Wound Healing in Burn Patients
A Study To Evaluate the Safety and Efficacy of Fibrin Sealant With 4IU/mL Thrombin, Vapor Heated, Solvent Detergent Treated (FS 4IU VH S/D) to Adhere Tissues and Improve Wound Healing
Status: Enrolling
Updated:  4/19/2017
Clinical Research Facility
853
mi
from
Phoenix, AZ
Safety and Efficacy Study of FS 4 IU VH S/D (Fibrin Sealant With 4IU/mL Thrombin, Vapor Heated, Solvent/Detergent Treated) to Adhere Split Thickness Skin Grafts and Improve Wound Healing in Burn Patients
A Study To Evaluate the Safety and Efficacy of Fibrin Sealant With 4IU/mL Thrombin, Vapor Heated, Solvent Detergent Treated (FS 4IU VH S/D) to Adhere Tissues and Improve Wound Healing
Status: Enrolling
Updated: 4/19/2017
Clinical Research Facility
853
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Safety and Efficacy Study of FS 4 IU VH S/D (Fibrin Sealant With 4IU/mL Thrombin, Vapor Heated, Solvent/Detergent Treated) to Adhere Split Thickness Skin Grafts and Improve Wound Healing in Burn Patients
A Study To Evaluate the Safety and Efficacy of Fibrin Sealant With 4IU/mL Thrombin, Vapor Heated, Solvent Detergent Treated (FS 4IU VH S/D) to Adhere Tissues and Improve Wound Healing
Status: Enrolling
Updated:  4/19/2017
Clinical Research Facility
1154
mi
from
Orange, CA
Safety and Efficacy Study of FS 4 IU VH S/D (Fibrin Sealant With 4IU/mL Thrombin, Vapor Heated, Solvent/Detergent Treated) to Adhere Split Thickness Skin Grafts and Improve Wound Healing in Burn Patients
A Study To Evaluate the Safety and Efficacy of Fibrin Sealant With 4IU/mL Thrombin, Vapor Heated, Solvent Detergent Treated (FS 4IU VH S/D) to Adhere Tissues and Improve Wound Healing
Status: Enrolling
Updated: 4/19/2017
Clinical Research Facility
1154
mi
from
Orange, CA
Click here to add this to my saved trials
Safety and Efficacy Study of FS 4 IU VH S/D (Fibrin Sealant With 4IU/mL Thrombin, Vapor Heated, Solvent/Detergent Treated) to Adhere Split Thickness Skin Grafts and Improve Wound Healing in Burn Patients
A Study To Evaluate the Safety and Efficacy of Fibrin Sealant With 4IU/mL Thrombin, Vapor Heated, Solvent Detergent Treated (FS 4IU VH S/D) to Adhere Tissues and Improve Wound Healing
Status: Enrolling
Updated:  4/19/2017
Clinical Research Facility
1278
mi
from
Sacramento, CA
Safety and Efficacy Study of FS 4 IU VH S/D (Fibrin Sealant With 4IU/mL Thrombin, Vapor Heated, Solvent/Detergent Treated) to Adhere Split Thickness Skin Grafts and Improve Wound Healing in Burn Patients
A Study To Evaluate the Safety and Efficacy of Fibrin Sealant With 4IU/mL Thrombin, Vapor Heated, Solvent Detergent Treated (FS 4IU VH S/D) to Adhere Tissues and Improve Wound Healing
Status: Enrolling
Updated: 4/19/2017
Clinical Research Facility
1278
mi
from
Sacramento, CA
Click here to add this to my saved trials
Safety and Efficacy Study of FS 4 IU VH S/D (Fibrin Sealant With 4IU/mL Thrombin, Vapor Heated, Solvent/Detergent Treated) to Adhere Split Thickness Skin Grafts and Improve Wound Healing in Burn Patients
A Study To Evaluate the Safety and Efficacy of Fibrin Sealant With 4IU/mL Thrombin, Vapor Heated, Solvent Detergent Treated (FS 4IU VH S/D) to Adhere Tissues and Improve Wound Healing
Status: Enrolling
Updated:  4/19/2017
Clinical Research Facility
1143
mi
from
San Diego, CA
Safety and Efficacy Study of FS 4 IU VH S/D (Fibrin Sealant With 4IU/mL Thrombin, Vapor Heated, Solvent/Detergent Treated) to Adhere Split Thickness Skin Grafts and Improve Wound Healing in Burn Patients
A Study To Evaluate the Safety and Efficacy of Fibrin Sealant With 4IU/mL Thrombin, Vapor Heated, Solvent Detergent Treated (FS 4IU VH S/D) to Adhere Tissues and Improve Wound Healing
Status: Enrolling
Updated: 4/19/2017
Clinical Research Facility
1143
mi
from
San Diego, CA
Click here to add this to my saved trials
Safety and Efficacy Study of FS 4 IU VH S/D (Fibrin Sealant With 4IU/mL Thrombin, Vapor Heated, Solvent/Detergent Treated) to Adhere Split Thickness Skin Grafts and Improve Wound Healing in Burn Patients
A Study To Evaluate the Safety and Efficacy of Fibrin Sealant With 4IU/mL Thrombin, Vapor Heated, Solvent Detergent Treated (FS 4IU VH S/D) to Adhere Tissues and Improve Wound Healing
Status: Enrolling
Updated:  4/19/2017
Clinical Research Facility
1047
mi
from
Gainesville, FL
Safety and Efficacy Study of FS 4 IU VH S/D (Fibrin Sealant With 4IU/mL Thrombin, Vapor Heated, Solvent/Detergent Treated) to Adhere Split Thickness Skin Grafts and Improve Wound Healing in Burn Patients
A Study To Evaluate the Safety and Efficacy of Fibrin Sealant With 4IU/mL Thrombin, Vapor Heated, Solvent Detergent Treated (FS 4IU VH S/D) to Adhere Tissues and Improve Wound Healing
Status: Enrolling
Updated: 4/19/2017
Clinical Research Facility
1047
mi
from
Gainesville, FL
Click here to add this to my saved trials
Safety and Efficacy Study of FS 4 IU VH S/D (Fibrin Sealant With 4IU/mL Thrombin, Vapor Heated, Solvent/Detergent Treated) to Adhere Split Thickness Skin Grafts and Improve Wound Healing in Burn Patients
A Study To Evaluate the Safety and Efficacy of Fibrin Sealant With 4IU/mL Thrombin, Vapor Heated, Solvent Detergent Treated (FS 4IU VH S/D) to Adhere Tissues and Improve Wound Healing
Status: Enrolling
Updated:  4/19/2017
Clinical Research Facility
600
mi
from
Maywood, IL
Safety and Efficacy Study of FS 4 IU VH S/D (Fibrin Sealant With 4IU/mL Thrombin, Vapor Heated, Solvent/Detergent Treated) to Adhere Split Thickness Skin Grafts and Improve Wound Healing in Burn Patients
A Study To Evaluate the Safety and Efficacy of Fibrin Sealant With 4IU/mL Thrombin, Vapor Heated, Solvent Detergent Treated (FS 4IU VH S/D) to Adhere Tissues and Improve Wound Healing
Status: Enrolling
Updated: 4/19/2017
Clinical Research Facility
600
mi
from
Maywood, IL
Click here to add this to my saved trials
Safety and Efficacy Study of FS 4 IU VH S/D (Fibrin Sealant With 4IU/mL Thrombin, Vapor Heated, Solvent/Detergent Treated) to Adhere Split Thickness Skin Grafts and Improve Wound Healing in Burn Patients
A Study To Evaluate the Safety and Efficacy of Fibrin Sealant With 4IU/mL Thrombin, Vapor Heated, Solvent Detergent Treated (FS 4IU VH S/D) to Adhere Tissues and Improve Wound Healing
Status: Enrolling
Updated:  4/19/2017
Clinical Research Facility
460
mi
from
Springfield, IL
Safety and Efficacy Study of FS 4 IU VH S/D (Fibrin Sealant With 4IU/mL Thrombin, Vapor Heated, Solvent/Detergent Treated) to Adhere Split Thickness Skin Grafts and Improve Wound Healing in Burn Patients
A Study To Evaluate the Safety and Efficacy of Fibrin Sealant With 4IU/mL Thrombin, Vapor Heated, Solvent Detergent Treated (FS 4IU VH S/D) to Adhere Tissues and Improve Wound Healing
Status: Enrolling
Updated: 4/19/2017
Clinical Research Facility
460
mi
from
Springfield, IL
Click here to add this to my saved trials